Search Results 1471-1480 of 19378 for hemoglobin

  1. Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL;; Total bilirubin ≤ 1.5 x the upper limit of the normal range (ULN);; Aspartate aminotransferase (AST) ≤ 3 x ULN;; Alanine ...

  2. A Study To Investigate The Efficacy, Safety, And Pharmacokinetics Of Oral Rilzabrutinib Compared With Placebo In Participants 18 Years Of Age And Older With Warm Autoimmune Hemolytic Anemia - Mayo Clinic

    * Participants who have previously failed to maintain a sustained response after treatment with CS (CS-resistance \[defined as failure to obtain hemoglobin ...

  3. Stories for Change: Digital Storytelling for Diabetes Self-Management among Hispanic Adults - Mayo Clinic

    Most recent hemoglobin A1c≥8%, and; Intention to continue to receive medical care at the recruitment clinic for the next six months. Participating Mayo ...

  4. 177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer - Mayo Clinic

    - Hemoglobin ≥ 9 g/dL - Hepatic: - Total bilirubin < 2 x the institutional upper limit of normal (ULN). For participants with known Gilbert's Syndrome ≤ 3 ...

  5. Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer - Mayo Clinic

    Hemoglobin (Hgb) within normal limits for institution/lab; Platelet count ≥ 100,000/ul; White blood cell count (WBC) ≥ 3,000/ul; Alanine aminotransferase ...

  6. MC200404, Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Late-stage Metastatic Colorectal Cancer - Mayo Clinic

    Hemoglobin ≥ 9 g/dL;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤3 x ULN (≤5 x ULN for patients with ...

  7. A Study to Evaluate Topical VT30 to Treat Patients with Venous/Lymphatic Malformations Associated with PIK3CA or TEK Gene Mutations - Mayo Clinic

    Hemoglobin A1c is > 8%. Any other clinically significant laboratory or testing abnormality that, in the opinion of the Investigator, might confound the ...

  8. A Study of DCC-2618 vs. Sunitinib in Advanced GIST Patients after Treatment with Imatinib - Mayo Clinic

    Hemoglobin ≥ 8 g/dL;; Platelet count ≥ 75,000/μ;; Total bilirubin ≤ 1.5 x the upper limit of normal (ULN);; Aspartate transaminase (AST) and alanine ...

  9. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Hemoglobin* ≥ 9g/dL. Renal: eGFR (CKD-EPI calculation) ≥ 30 mL/min/1.73m^2. Hepatic: Serum total bilirubin ≤ 1.5 x ULN; or; Direct bilirubin ≤ ULN for ...

  10. Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial) - Mayo Clinic

    Hemoglobin < 8.0 g/dl, uncorrectable INR > 3.05, or platelet count < 75,000/ml. Severe renal impairment (on chronic dialysis or estimated GFR < 30 ml/min) ...